Articles from: medRxiv
Mashup Score:1799
medRxivBrain imaging before and after COVID-19 in UK Biobank - 11 hours
Mashup Score:1799
There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain...
-
Many thanks @Phil_Mattingly for hosting me @cnn. Here’s the @medrxivpreprint I discussed and why I think it’s important to vaccinate not only to prevent hospitalizations and deaths but also infection and longCovid neurological damage https://t.co/0ZBHW4gZUq - view on twitter
Vaccine-mediated immunity often relies on the generation of protective antibodies and memory B cells, which commonly stem from germinal center (GC) reactions. An in-depth...
-
RT @LocciLab: Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals https://t.co/QSrvD4mRij - view on twitter
Mashup Score:7
medRxivAnti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin - 1 day
Mashup Score:7
Background COVID-19 vaccines have been associated with a rare thrombotic and thrombocytopenic reaction, Vaccine-induced immune thrombotic thrombocytopenia (VITT) characterized by platelet-activating anti-PF4 antibodies. This...
-
Great to collaborate with my colleagues on this truly fascinating study on the clonality of anti-PF4 antibodies seen in #VITT https://t.co/VqbfSIcMf6 @AnandPheresisMD @SmockKristi @UofUHealth @MayoClinic @ARUPLabs #COVID19 - view on twitter
With high levels of the Delta variant of COVID-19 circulating in England during September 2021, schools are set to reopen with few school-based non-pharmaceutical...
-
RT @bnlawrence: Just submitted our paper on safe opening of schools: https://t.co/nodKLzZC29. A thread. But first caveats: this presents… - view on twitter
Mashup Score:1
medRxivWhile the standard regimen of the BNT162b2 mRNA vaccine includes two doses administered three weeks apart, some public health authorities decided to space them,...
-
Strong humoral immune responses against SARS-CoV-2 Spike after Pfizer BNT162b2 mRNA vaccination with a 16 week interval between doses https://t.co/zvZOgxawpW 2nd dose of Pfizer after 16 weeks produced a much higher level of antibodies c/w levels in previously infected ppl. https://t.co/zvZOgxawpW - view on twitter
Summary: Background More contagious SARS-CoV-2 virus variants, breakthrough infections, waning immunity, and differential access to COVID-19 vaccines account for the worst yet numbers of...
-
Development and evaluation of a machine learning-based in-hospital COvid-19 Disease Outcome Predictor (CODOP): a multicontinental retrospective study | medRxiv https://t.co/Vb68XsLhsx - view on twitter
Mashup Score:4
medRxivSeroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients over six months - 3 days
Mashup Score:4
Background and Objectives While most maintenance dialysis patients exhibit initial seroresponse to vaccination, concerns remain regarding the durability of this antibody response. This study...
-
Other aspects worth knowing: -Actual antibody titres are *lower* in dialysis patients compared to healthy controls, even after 2 doses -Titres do wane with time https://t.co/nRMZ1TPWB8 #NephJC https://t.co/nRMZ1TPWB8 - view on twitter
More coverage:
#nephjc
Mashup Score:7
medRxivSeroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients over six months - 3 days
Mashup Score:7
Background and Objectives While most maintenance dialysis patients exhibit initial seroresponse to vaccination, concerns remain regarding the durability of this antibody response. This study...
-
The same preprint also suggests some vaccines may be better than others (observational data) https://t.co/5ghJvBdaSz #NephJC https://t.co/5ghJvBdaSz - view on twitter
-
The preprint https://t.co/5ghJvBuLK7 also has some data on antibody titres and association with infections See #NephJC https://t.co/5ghJvBuLK7 - view on twitter
More coverage:
#nephjc
Mashup Score:5
medRxivThe US FDA has recently authorized immunocompromised people to receive a third dose of mRNA Covid-19 vaccine following the two-doses regimen to further boost...
-
If 3 doses are good, can 4 doses in transplant be better? Yes: https://t.co/FF0ZWDC4RS #NephJC https://t.co/FF0ZWDC4RS - view on twitter
More coverage:
#nephjc
Objectives To determine whether COVID-19 efficacy varies with clinical risk category and to investigate risk factors for severe COVID-19 in those who have received...
Efficacy of two doses of COVID-19 vaccine against severe COVID-19 in those with risk conditions and residual risk to the clinically extremely vulnerable: the REACT-SCOT case-control study https://t.co/naQhZ0sNVS. - view on twitter